ATLAS: A phase II, open-label study of rucaparib in patients (pts) with locally advanced (unresectable) or metastatic urothelial carcinoma

被引：0

作者：

Chowdhury, S. ^{[1
,2
]}

Feyerabend, S. ^{[3
]}

Loriot, Y. ^{[4
]}

Necchi, A. ^{[5
]}

Gupta, S. ^{[6
]}

Josephs, D. H. ^{[7
]}

Rodriguez-Vida, A. ^{[8
]}

Srinivas, S. ^{[9
]}

Zakharia, Y. ^{[10
,11
]}

Nepert, D. ^{[12
]}

Wride, K. ^{[13
]}

Thomas, D. ^{[14
]}

Loehr, A. ^{[15
]}

Simmons, A. D. ^{[15
]}

Grivas, P. ^{[16
]}

机构：

[1] Guys Hosp, Med Oncol, London, England

[2] Sarah Cannon Res Inst, London, England

[3] Studienpraxis Urol, Urol Oncol, Nurtingen, Germany

[4] Gustave Roussy, Dept Canc Med, Canc Campus, Villejuif, France

[5] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy

[6] Univ Utah, Huntsman Canc Inst, Genitourinary Oncol Program, Salt Lake City, UT USA

[7] Guys & St Thomas Hosp, Dept Med Oncol, London, England

[8] Hosp del Mar, Genitourinary Canc Unit, Barcelona, Spain

[9] Stanford Univ, Sch Med, Urol Oncol Clin, Stanford, CA 94305 USA

[10] Univ Iowa, Div Hematol, Iowa City, IA USA

[11] Holden Comprehens Canc Ctr, Iowa City, IA USA

[12] Clovis Oncol Inc, Clin Sci, Boulder, CO USA

[13] Clovis Oncol Inc, Biostat, Boulder, CO USA

[14] Clovis Oncol Inc, Clin Operat, Boulder, CO USA

[15] Clovis Oncol Inc, Translat Med, Boulder, CO USA

[16] Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

928TiP

引用

页数：1